BILLAMBOZ, Muriel; SUCHAUD, Virginie; BAILLY, Fabrice; LION, Cedric; ANDRÉOLA, Marie-Line; CHRIST, Frauke; DEBYSER, Zeger; COTELLE, Philippe

doi:10.1016/j.ejmech.2016.03.083

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

Idioma

Article de revue

Este ítem está publicado en

European Journal of Medicinal Chemistry. 2016-07-19, vol. 117, p. 256-68

Resumen en inglés

Herein, we report further insight into the biological activities displayed by the 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) scaffold. Previous studies have evidenced the marked fruitful effect of substitution of this two-metal binding pharmacophore at position 4 by phenyl and benzyl carboxamido chains. Strong human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitors in the low nanomolar range with micromolar (even down to low nanomolar) anti-HIV activities were obtained. Keeping this essential 4-carboxamido function, we investigated the influence of the replacement of phenyl and benzyl groups by various alkyl chains. This study shows that the recurrent halogenobenzyl pharmacophore found in the INSTIs can be efficiently replaced by an n-alkyl group. With an optimal length of six carbons, we observed a biological profile and a high barrier to resistance equivalent to those of a previously reported hit compound bearing a 4-fluorobenzyl group.< Leer menos

Palabras clave en inglés

Alkylation

Anti-HIV Agents

Cell Line

Drug Resistance

Viral

HIV Integrase Inhibitors

Humans

Isoquinolines

Structure-Activity Relationship

Metadatos

Compartir este ítem

Licencia de uso del documento

2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación